Login to Your Account

Evolva's U.S. Subsidiary Gets $23M Army Contract

By Cormac Sheridan

Wednesday, May 21, 2008
Genetic Chemistry Inc., a Bay Area subsidiary of Evolva SA, secured a contract worth up to $22.8 million from the U.S. Army Research Office to discover and develop novel compounds that act against the Gram-negative bacterium Burkholderia pseudomallei. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription